B7H3 As a Promoter of Metastasis and Promising Therapeutic Target

B7H3 (also known as CD276, an immune checkpoint molecule) is aberrantly overexpressed in many types of cancer, and such upregulation is generally associated with a poor clinical prognosis. Recent discoveries indicate a crucial role for B7H3 in promoting carcinogenesis and metastasis. This review wil...

Descripción completa

Detalles Bibliográficos
Autores principales: Dong, Peixin, Xiong, Ying, Yue, Junming, Hanley, Sharon J. B., Watari, Hidemichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6043641/
https://www.ncbi.nlm.nih.gov/pubmed/30035102
http://dx.doi.org/10.3389/fonc.2018.00264

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6043641/
https://www.ncbi.nlm.nih.gov/pubmed/30035102
http://dx.doi.org/10.3389/fonc.2018.00264

Ejemplares similares